Initial Response and Outcome of Critically Ill Children With Guillain Barre' Syndrome

Hafez M Bazaraa1, Hanaa I Rady1, Shereen A Mohamed1

  • 1Department of Pediatrics, Kasr Alainy Faculty of Medicine, Cairo University, Cairo, Egypt.

Frontiers in Pediatrics
|October 18, 2019
PubMed

Insights

Severe pediatric Guillain-Barre syndrome (GBS) cases admitted to the ICU show a guarded response to initial treatments like plasma exchange (PE) or intravenous immunoglobulins (IVIg). Many children with GBS experience axonal neuropathy, impacting their recovery and outcomes.

Area of Science:

  • Pediatric Neurology
  • Critical Care Medicine
  • Neuromuscular Disorders

Background:

  • Guillain-Barre syndrome (GBS) is a leading cause of acute flaccid paralysis globally.
  • Severe GBS can necessitate intensive care unit (ICU) admission and mechanical ventilation.

Purpose of the Study:

  • To evaluate pediatric patients with severe GBS admitted to the ICU.
  • To assess the clinical course and treatment response to plasma exchange (PE) or intravenous immunoglobulins (IVIg).
  • To determine the final outcomes in these critically ill children.

Main Methods:

  • Enrolled children with severe GBS presenting with respiratory failure, bulbar involvement, or rapid paralysis progression.
  • Administered initial treatment with PE (5 sessions) or IVIg.
  • Assessed patient improvement, treatment failure, and functional outcomes at discharge.

Main Results:

  • 40 children were included; 16 improved (40%), 2 died, and 22 (55%) showed initial treatment failure.
  • Axonal neuropathy, rapid progression, and severe motor weakness predicted a poor treatment response.
  • Favorable outcomes (unaided walking) were achieved in 22 cases (58%) at discharge.

Conclusions:

  • Critically ill children with severe GBS have a high prevalence of axonal neuropathy.
  • Initial therapies (PE or IVIg) yielded a guarded response in this cohort.
  • While mortality is relatively low, functional recovery remains a significant challenge.